Global Healthy Living Foundation has 12 posters and Polymyalygia Rheumataca, Psoriasis and RA Research at American College of ...

Polymyalgia rheumatica (PMR) is a common inflammatory condition affecting elderly people and involving the girdles. [1] The mainstay of treatment is oral glucocorticoids (GC), with the recent BSR ...

The Lupus Foundation of America (LFA), along with numerous researchers funded by the Foundation, will present novel lupus discoveries as part of the American College of Rheumatology Convergence 2024 ...

Veeva Systems today announced that Boehringer Ingelheim is the latest global top 20 biopharma company to commit to moving to Veeva Vault ...

However, since no comparison was made between different treatments, we think it could not have biased the results. Responders reached clinical remission in 6.6 days in average; most of them within ...

PUDUCHERRY: Urging the Lieutenant Governor to address claims of a lack of proper machinery in manufacturing corrective ...

Before I even finish my story, he says: “Polymyalgia rheumatica. I’ve had it ... so my mood and energy levels remain stable. Others new treatments are currently under development, but they are not yet ...

Operator Good morning and good afternoon, and welcome to the Novartis Q3 2024 results release conference call and live ...

Treatment for viral arthritis is normally focused on pain ... Other characteristics of sarcoidosis that help to distinguish ...

Background: Glucocorticoids (GC) are the cornerstone of the treatment of polymyalgia rheumatica (PMR) and giant cell arteritis (GCA), but they are associated with several adverse events (AEs).

Background Glucocorticoids are the cornerstone treatment of polymyalgia rheumatica (PMR) but induce adverse events. Objectives To evaluate the efficacy and safety of first-line tocilizumab in PMR.

Despite these delays, all AHA patients in the study achieved remission after receiving treatments to stop bleeding and ... A ...